All Type of News
Domestic companies will have delay on launching blockbuster ‘Trajenta’ generics
Domestic generic companies failed in challenging the substance patent of antidiabetic ‘Trajenta.’
In the past, domestic companies won nullification suits for its crystalline and formulation patents which are expiring...
“Remote medicine dispenser must require enough demo projects before implemented”
An opinion of the National Assembly Research Service was proposed that enough demo projects must precede before actively implementing remote medicine dispensers.
On the 29th, the National Assembly Research Service pu...
Medical industry shocked by Supreme Court’s ruling on Fraxel Laser procedures
The medical industry was shocked as the Supreme Court made a ruling that dentists’ cosmetic laser procedures are lawful as well as their cosmetic botox procedures.
On July 21, 2016, the Supreme Court ruled cancella...
Targeted therapy for HER2-negative breast cancer, ‘Ibrance’ acquires approval
Silent for more than ten years. a targeted therapy for Human Epidermal Growth Factor Receptor 2(HER2)-negative breast cancer acquired approval of commercialization in Korea.
On the 29th, the Ministry of Food and Drug...
Well-matched contest in basal insulin market between Sanofi and Novo Nordisk
Competition is getting fiercer in the market of next-generation basal insulin which might replace Lantus. Sanofi and Novo Nordisk are even having a publicity war to show off their companies’ performances.
Novo Nordis...
Police, “Kim Young-ran Law will be enforced without guidance period as scheduled”
The Anti-Corruption and Bribery Prohibition Law, Kim Young-ran Law will be enforced from the 28th of September without a guidance period, and the ceiling prices will be kept as KRW 30 thousand(Meals), KRW 50 thousand(...
Will return of President Jay-Hyun Lee accelerate IPO process?As President Jay-Hyun Lee of CJ Group went free by the President’s special pardons on the Liberation Day, CJ HealthCare is expected to accelerate a procedure to go public.
CJ...
|
Kwang Dong’s targeted therapy Afinitor challenges to patent
Kwang Dong Pharmaceutical started to develop a first generic of ‘Afinitor(generic name: everolimus),’ a Novartis’ targeted therapy.
Used to treat diseases such as breast cancer and renal cancer, Afinitor is recording...
Pharmacy circles, Harvoni & Sovaldi are pies in the sky unless having cash power
A phenomenon to avoid Gilead’s hepatitis C treatments which cost millions of wons ‘Harvoni’ and ‘Sovaldi’ is getting intensified. Since both local and hospital pharmacies are avoiding to dispense the drugs, it is unco...
Competition in long-acting schizophrenia injections between Otsuka and Janssen
When it comes to treating schizophrenia, competition among long-acting injections(LAIs) is about to be intensified.
This is because a series of new drug launches are expected for schizophrenia patients who are havin...
